Annual Drug Patent Expirations for SOHONOS
Sohonos is a drug marketed by Ipsen and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has forty-eight patent family members in twenty-two countries.
The generic ingredient in SOHONOS is palovarotene. One supplier is listed for this compound. Additional details are available on the palovarotene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com